 |
|
Relation of Low Body Mass to Death and Stroke in the Systolic Hypertension in the Elderly Program
Sylvia Wassertheil-Smoller, PhD;
Cathy Fann, PhD;
Richard M. Allman, MD;
Henry R. Black, MD;
Greta H. Camel, MD;
Barry Davis, MD, PhD;
Kamal Masaki, MD;
Sarah Pressel, MS;
Ronald J. Prineas, MB, BS, PhD;
Jeremiah Stamler, MD;
Thomas M. Vogt, MD, MPH;
for the SHEP Cooperative Research Group
Arch Intern Med. 2000;160:494-500.
Background There are scant data on the effect of body mass index (BMI) (calculated as weight in kilograms divided by the square of height in meters) on cardiovascular events and death in older patients with hypertension.
Objective To determine if low body mass in older patients with hypertension confers an increased risk of death or stroke.
Patients Participants were 3975 men and women (mean age, 71 years) enrolled in 17 US centers in the Systolic Hypertension in the Elderly Program trial, a randomized, double-blind, placebo-controlled clinical trial of low-dose antihypertensive therapy, with follow-up for 5 years.
Main Outcome Measures Five-year adjusted mortality and stroke rates from Cox proportional hazards analyses.
Results There was no statistically significant relation of death or stroke with BMI in the placebo group (P = .47), and there was a U- or J-shaped relation in the treatment group. The J-shaped relation of death with BMI in the treated group (P = .03) showed that the lowest probability of death for men was associated with a BMI of 26.0 and for women with a BMI of 29.6; the curve was quite flat for women across a wide range of BMIs. For stroke, men and women did not differ, and the BMI nadir for both sexes combined was 29, with risk increasing steeply at BMIs below 24. Those in active treatment, however, had lower death and stroke rates compared with those taking placebo.
Conclusions Among older patients with hypertension, a wide range of BMIs was associated with a similar risk of death and stroke; a low BMI was associated with increased risk. Lean, older patients with hypertension in treatment should be monitored carefully for additional risk factors.
From the Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY (Drs Wassertheil-Smoller and Fann); Division of Gerontology, Department of Medicine, the University of Alabama at Birmingham, and the Veterans Affairs Medical Center, Birmingham (Dr Allman); Departments of Preventive Medicine, Rush–Presbyterian–St Luke's Medical Center (Dr Black) and Northwestern University Medical School (Dr Stamler), Chicago, Ill; Hypertension Division, Washington University School of Medicine, St Louis, Mo (Dr Camel); Department of Biometry, University of Texas Health Science Center, Houston (Dr Davis and Ms Pressel); Division of Geriatric Medicine, the John A. Burns School of Medicine (Dr Masaki) and the Center for Health Research, Kaiser Permanente (Dr Vogt), Honolulu, Hawaii; and the Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC (Dr Prineas). A complete list of the members of the SHEP Cooperative Research Group appears in JAMA (1991;265:3255-3264).
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(4):555-556.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy: The LIFE (Losartan Intervention For Endpoint reduction in hypertension) Study
de Simone et al.
Circulation 2005;111:1924-1931.
ABSTRACT
| FULL TEXT
Survival advantages of obesity in dialysis patients
Kalantar-Zadeh et al.
Am. J. Clin. Nutr. 2005;81:543-554.
ABSTRACT
| FULL TEXT
Body Mass Index and Total and Cardiovascular Mortality in Men With a History of Cardiovascular Disease
Widlansky et al.
Arch Intern Med 2004;164:2326-2332.
ABSTRACT
| FULL TEXT
Estimating Deaths Attributable to Obesity in the United States
Flegal et al.
Am. J. Public Health 2004;94:1486-1489.
ABSTRACT
| FULL TEXT
Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure
Kalantar-Zadeh et al.
J Am Coll Cardiol 2004;43:1439-1444.
ABSTRACT
| FULL TEXT
Body Weight, Blood Pressure, and Mortality in a Cohort of Obese Patients
Bender et al.
Am J Epidemiol 2002;156:239-245.
ABSTRACT
| FULL TEXT
Body Mass Index, Weight Change, and Death in Older Adults: The Systolic Hypertension in the Elderly Program
Somes et al.
Am J Epidemiol 2002;156:132-138.
ABSTRACT
| FULL TEXT
The relationship between obesity and mortality in patients with heart failure
Horwich et al.
J Am Coll Cardiol 2001;38:789-795.
ABSTRACT
| FULL TEXT
Race-Ethnic Disparities in the Impact of Stroke Risk Factors: The Northern Manhattan Stroke Study
Sacco et al.
Stroke 2001;32:1725-1731.
ABSTRACT
| FULL TEXT
Contrasting clinical properties and exercise responses in obese and lean hypertensive patients
Weber et al.
J Am Coll Cardiol 2001;37:169-174.
ABSTRACT
| FULL TEXT
|
